Several companies are developing PET amyloid imaging agents labeled with [18 F] that could be transported long distances to hospitals and clinics. For this partially manufacturer-funded study ...

The revised criteria offer guidance for clinicians to determine when amyloid and tau PET are recommended. Criteria were divided into 17 common clinical scenarios with three subcategories of ...

F RIDAY, Jan. 17, 2025 (HealthDay News) -- Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer's Association and the ...